Stock listing

Frankfurt:JNY JW (Cayman) Therapeutics Co. Ltd. Aktie

German listing (Frankfurt) of JW (Cayman) Therapeutics Co. Ltd. · home listing HKEX:2126

Follow JW (Cayman) Therapeutics Co. Ltd. into a list and get an email when it puts out news.

Share price · FWB:JNY

€0.242 EUR +0.010 (+4.3%)

Close on Oct 30, 2026

Day range
€0.232 – €0.242 EUROct 30, 2026
Market cap
€100.8M EURAt the close on Oct 30, 2026 · price × 416.7M shares outstanding
JW (Cayman) Therapeutics Co. Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
HKEX:2126 · Home$2.19 HKD-0.03 (-1.4%)515,500$2.285$2.285$2.10$2.22Close on Nov 3, 2026
Frankfurt:JNY€0.242 EUR+0.010 (+4.3%)—€0.232€0.242€0.232€0.232Close on Oct 30, 2026
Ticker
Frankfurt:JNY
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026

Oct 7, 2026

2026 Interim report

Sep 24, 2026

JW Therapeutics and Regeneron Expand Strategic Collaboration Agreement to Advance TCR-T Cell Therapy Development and Maximize Global Platform Potential

Oct 31, 2025

JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao

Jun 4, 2025

JW Therapeutics - Receipt of Breakthrough Therapy Designation for Carteyva in China as Second-line Treatment in Relapsed or Refractory adult Large B-cell Lymphoma

Jan 13, 2025

JW Therapeutics Announces Initiation of Clinical Study of JWATM204 in Patients with Advanced Hepatocellular Carcinoma

Jul 4, 2022

JW Therapeutics Announces IND Approval for the Pivotal Clinical Trial of Carteyva® in Second-line Large B-Cell Lymphoma

Mar 31, 2022

JW (Cayman) Therapeutics: Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China

Sep 6, 2021

Change of company secretary, authorized representative and process agent

Jul 30, 2021

JW (Cayman) Therapeutics: Proposals for general mandates to issue shares and repurchase shares and re-election of retiring directors and re-appointment of auditor and notice of annual general meeting

Apr 23, 2021

All JW (Cayman) Therapeutics Co. Ltd. news

Decks

JW (Cayman) Therapeutics Co. Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 11 in all · newest Oct 7, 2026 · oldest 2021
Decks
7 decks · latest 2025

Where JW (Cayman) Therapeutics Co. Ltd. is listed

ListingExchangeCountryCurrency
HKEX:2126 藥明巨諾 · Home listingHKEXHong KongHKD
LS Exchange:A2QFV3LS ExchangeGermanyEUR
Frankfurt:JNY · This pageFrankfurtGermanyEUR
Lang & Schwarz:A2QFV3Lang & SchwarzGermanyEUR
OTC:JWCTFOTCUnited StatesUSD

Log in to ask 6ix AI your own questions about JW (Cayman) Therapeutics Co. Ltd.